UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Is a Universal Influenza Virus Vaccine Possible?

Annual review of medicine, 2020-01, Vol.71 (1), p.315-327

2020

Volltextzugriff (PDF)

Toward a Universal Influenza Virus Vaccine: Prospects and Challenges

Annual review of medicine, 2013-01, Vol.64 (1), p.189-202

2013

Volltextzugriff (PDF)

Overcoming Barriers in the Path to a Universal Influenza Virus Vaccine

Cell host & microbe, 2018-07, Vol.24 (1), p.18-24

2018

Volltextzugriff (PDF)

Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions

Future microbiology, 2012-03, Vol.7 (3), p.347-367

2012

Volltextzugriff (PDF)

A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine

PLoS pathogens, 2017-10, Vol.13 (10), p.e1006682-e1006682

2017

Volltextzugriff (PDF)

Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1

PLoS pathogens, 2005-09, Vol.1 (1), p.e4-e4

2005

Volltextzugriff (PDF)

Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets

mBio, 2020-05, Vol.11 (3)

2020

Volltextzugriff (PDF)

Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies

Journal of Virology, 2013-06, Vol.87 (12), p.6542-6550

2013

Volltextzugriff (PDF)

Universal influenza virus vaccines: need for clinical trials

Nature immunology, 2014-01, Vol.15 (1), p.3-5

2014

Volltextzugriff (PDF)

Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2

mBio, 2020-09, Vol.11 (5)

2020

Volltextzugriff (PDF)

Guiding the Immune Response against Influenza Virus Hemagglutinin toward the Conserved Stalk Domain by Hyperglycosylation of the Globular Head Domain

Journal of Virology, 2014-01, Vol.88 (1), p.699-704

2014

Volltextzugriff (PDF)

Making better influenza virus vaccines?

Emerging infectious diseases, 2006-01, Vol.12 (1), p.61-65

Palese, Peter

2006

Volltextzugriff (PDF)

Phase Transitions Drive the Formation of Vesicular Stomatitis Virus Replication Compartments

mBio, 2018-09, Vol.9 (5)

2018

Volltextzugriff (PDF)

Impaired Cytotoxic CD8 + T Cell Response in Elderly COVID-19 Patients

mBio, 2020-09, Vol.11 (5)

2020

Volltextzugriff (PDF)

Development of Influenza B Universal Vaccine Candidates Using the "Mosaic" Hemagglutinin Approach

Journal of virology, 2019-06, Vol.93 (12)

2019

Volltextzugriff (PDF)

Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy

Science translational medicine, 2014-03, Vol.6 (226), p.226ra32

2014

Volltextzugriff (PDF)

Influenza virus transmission is dependent on relative humidity and temperature

PLoS pathogens, 2007-10, Vol.3 (10), p.1470-1476

2007

Volltextzugriff (PDF)

Genetic Surveillance of SARS-CoV-2 Mpro Reveals High Sequence and Structural Conservation Prior to the Introduction of Protease Inhibitor Paxlovid

mBio, 2022-08, Vol.13 (4), p.e0086922-e0086922

2022

Volltextzugriff (PDF)

Characterization of a novel influenza virus in cattle and Swine: proposal for a new genus in the Orthomyxoviridae family

mBio, 2014-03, Vol.5 (2), p.e00031

2014

Volltextzugriff (PDF)

Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19

The Lancet (British edition), 2020-03, Vol.395 (10226), p.e42-e43

2020

Volltextzugriff (PDF)

Antagonism of dsRNA-Induced Innate Immune Pathways by NS4a and NS4b Accessory Proteins during MERS Coronavirus Infection

mBio, 2019-03, Vol.10 (2)

2019

Volltextzugriff (PDF)

Oncolytic Specificity of Newcastle Disease Virus Is Mediated by Selectivity for Apoptosis-Resistant Cells

Journal of Virology, 2011-06, Vol.85 (12), p.6015-6023

2011

Volltextzugriff (PDF)

Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system

Journal of visualized experiments, 2013-11 (81), p.e51112-e51112

2013

Volltextzugriff (PDF)

Selective Degradation of Host RNA Polymerase II Transcripts by Influenza A Virus PA-X Host Shutoff Protein

PLoS pathogens, 2016-02, Vol.12 (2), p.e1005427-e1005427

2016

Volltextzugriff (PDF)

1 – 25 von 630

Suche als RSS-Feed

Aktive Filter

KollektionOxford journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(610)
Mit Volltextzugriff
(578)

Publikationsform

Artikel
(614)
Buchkapitel
(12)
Reviews
(4)

Sprache

Englisch
(628)
Japanisch
(210)
Deutsch
(1)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(498)
Life Sciences & Biomedicine
(374)
Animals
(299)
Humans
(297)
Virology
(237)
Microbiology
(233)
Viruses
(180)
Mice
(139)
Influenza
(126)
Multidisciplinary Sciences
(125)
Science & Technology - Other Topics
(125)
Cell Line
(112)
Influenza Virus
(101)
Biological And Medical Sciences
(97)
Influenza A Virus
(96)
Fundamental And Applied Biological Sciences. Psychology
(88)
Influenza A Virus - Genetics
(86)
Female
(83)
Molecular Sequence Data
(83)
Vaccines
(79)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Is a Universal Influenza Virus Vaccine Possible?

Toward a Universal Influenza Virus Vaccine: Prospects and Challenges

Overcoming Barriers in the Path to a Universal Influenza Virus Vaccine

Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions

A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine

Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1

Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets

Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies

Universal influenza virus vaccines: need for clinical trials

Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2

Guiding the Immune Response against Influenza Virus Hemagglutinin toward the Conserved Stalk Domain by Hyperglycosylation of the Globular Head Domain

Making better influenza virus vaccines?

Phase Transitions Drive the Formation of Vesicular Stomatitis Virus Replication Compartments

Impaired Cytotoxic CD8 + T Cell Response in Elderly COVID-19 Patients

The Substitutions L50F, E166A, and L167F in SARS-CoV-2 3CLpro Are Selected by a Protease Inhibitor In Vitro and Confer Resistance To Nirmatrelvir

Development of Influenza B Universal Vaccine Candidates Using the "Mosaic" Hemagglutinin Approach

Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy

Influenza virus transmission is dependent on relative humidity and temperature

Genetic Surveillance of SARS-CoV-2 Mpro Reveals High Sequence and Structural Conservation Prior to the Introduction of Protease Inhibitor Paxlovid

Characterization of a novel influenza virus in cattle and Swine: proposal for a new genus in the Orthomyxoviridae family

Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19

Antagonism of dsRNA-Induced Innate Immune Pathways by NS4a and NS4b Accessory Proteins during MERS Coronavirus Infection

Oncolytic Specificity of Newcastle Disease Virus Is Mediated by Selectivity for Apoptosis-Resistant Cells

Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system

Selective Degradation of Host RNA Polymerase II Transcripts by Influenza A Virus PA-X Host Shutoff Protein

Aktive Filter

Suchergebnisse filtern